Related Experiment Videos
Sample size calculation for a historically controlled clinical trial with adjustment for covariates
A James O'Malley1, Sharon-Lise T Normand, Richard E Kuntz
1Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA. omalley@hcp.med.harvard.edu
Journal of Biopharmaceutical Statistics
|November 5, 2002
Summary
Determining optimal sample size for historically controlled clinical trials is crucial. A new Bayesian approach using stochastic optimization offers more accurate calculations than traditional methods, improving trial reliability.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Medical Device Research
Background:
- Historically controlled trials (HCTs) often use retrospective control groups.
- Non-randomized controls necessitate advanced statistical methods (e.g., hierarchical regression, propensity scores) to mitigate bias from heterogeneity.
- Existing sample size calculations for HCTs, often adapted from randomized trials, neglect key factors like parameter estimation, observation correlation, and covariate uncertainty.
Purpose of the Study:
- To develop a Bayesian approach for optimal sample size determination in historically controlled clinical trials.
- To address deficiencies in current sample size calculation methods for HCTs, particularly for medical device trials.
- To provide a robust methodology that accounts for complexities inherent in retrospective control groups.
Main Methods:
- A Bayesian framework was employed for sample size optimization.
- Stochastic optimization techniques were utilized to overcome limitations of traditional methods.
- The methodology was demonstrated using a power-based objective function.
- Analytic approximations for covariate-free analyses were developed to understand power function characteristics.
Main Results:
- Proposed Bayesian methodology provides more accurate sample size calculations compared to existing approximations.
- Stochastic optimization offers a computationally efficient approach for complex sample size determination.
- The developed methods account for parameter estimation, observation correlation, and covariate distribution uncertainty.
- Exact sample size calculations can differ significantly from current approximations, impacting trial power and resource allocation.
Conclusions:
- The novel Bayesian approach with stochastic optimization enhances the accuracy of sample size determination for historically controlled clinical trials.
- This methodology is particularly relevant for medical device trials utilizing retrospective controls.
- Accurate sample size calculations are essential for ensuring adequate statistical power and reliable trial outcomes.
- Stochastic optimization presents a practical computational solution for complex sample size problems in clinical research.